Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Business Type:Trading Company

Audited Supplier

Main Products:: Remdesivir, Oseltamivir phosphate, Arbidol HCl (Umifenovir HCl), Iohexol, Iopromide, Ioversol, Iopamidol, Iodixanol,Iomeprol, Gadobenate Dimeglumine, Gadopentetate monomeglumine, Fipronil, Calcitrol, Virginiamycin, Bicalutamide, Abiraterone acetate, Nepafenac, Vitamin D3,Sodium Dibunate, Mycophenolate mofetil, Mycophenolate Sodium (APIs,Intermediates,Biochemicals)

Year Established:: 2014

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd (JL Pharm) is established in 2012 at the beautiful West Lake – Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include Anti-COVID products, Contrast Media, related formulation, intermediates, and new product development. We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhe...

Time of verification:	2020-7-07 16:45
Company Name:	Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
Country/Territory:	China (Mainland)
Registered Address:	Rm A606, Fuyi Center, jianqiao street, Jianggan Area
Company Scale:	51 - 100
Registered Capital:	5000000
Business Type:	True
Business Scope:	Remdesivir, Oseltamivir phosphate, Arbidol HCl (Umifenovir HCl), Iohexol, Iopromide, Ioversol, Iopamidol, Iodixanol,Iomeprol, Gadobenate Dimeglumine, Gadopentetate monomeglumine, Fipronil, Calcitrol, Virginiamycin, Bicalutamide, Abiraterone acetate, Nepafenac, Vitamin D3,Sodium Dibunate, Mycophenolate mofetil, Mycophenolate Sodium (APIs,Intermediates,Biochemicals)
Main Markets:	North America South America Eastern Europe Southeast Asia Africa Oceania Mid East Eastern Asia Western Europe
Company Corporate Representative:	CAO HUIHUI

Certificate

Business License:
Tax Registration Certificate:
Organization Code Certificate:
Legal person's id card:

Contact Supplier

Confirm to collect the company to my collection?